We expect this to trend down as visceral fat decreases, since visceral fat is itself a driver of chronic inflammation
BPC-157 has demonstrated enhanced healing in tendon ruptures, muscle tears, bone fractures, and even stomach ulcers in preclinical studies [5] [6]
Published in vitro and animal-model research has examined NNMT inhibition in connection with several areas of scientific interest, including adipocyte metabolism , NAD pathway regulation , mitochondrial function , and cellular energy signalling
NAD+ therapy (injections/IVs) excels, boosting levels, mitochondrial function, and energy.[20][21] Clinical evidence shows improvements in fatigue and metabolic markers, with some studies reporting enhanced quality of life